Drug – bio-affecting and body treating compositions – Effervescent or pressurized fluid containing – Organic pressurized fluid
Reexamination Certificate
2006-07-18
2006-07-18
Hartley, Michael G. (Department: 1616)
Drug, bio-affecting and body treating compositions
Effervescent or pressurized fluid containing
Organic pressurized fluid
C424S046000, C128S200140, C128S200240, C604S290000, C514S264110
Reexamination Certificate
active
07078016
ABSTRACT:
The present invention relates to the delivery of caffeine through an inhalation route. Specifically, it relates to aerosols containing caffeine that are used in inhalation therapy. In a composition aspect of the present invention, the aerosol comprises particles comprising at least 5 percent by weight of caffeine. In a method aspect of the present invention, caffeine is delivered to a mammal through an inhalation route. The method comprises: a) heating a composition, wherein the composition comprises at least 5 percent by weight of caffeine, to form a vapor; and, b) allowing the vapor to cool, thereby forming a condensation aerosol comprising particles, which is inhaled by the mammal. In a kit aspect of the present invention, a kit for delivering caffeine through an inhalation route to a mammal is provided which comprises: a) a composition comprising at least 5 percent by weight of caffeine; and, b) a device that forms a caffeine containing aerosol from the composition, for inhalation by the mammal.
REFERENCES:
patent: 3560607 (1971-02-01), Hartley et al.
patent: 3949743 (1976-04-01), Shanbrom
patent: 3982095 (1976-09-01), Robinson
patent: RE30285 (1980-05-01), Babington
patent: 4303083 (1981-12-01), Burruss, Jr.
patent: 4484576 (1984-11-01), Albarda
patent: 4566451 (1986-01-01), Badewien
patent: 4734560 (1988-03-01), Bowen
patent: 4735217 (1988-04-01), Gerth et al.
patent: 4853517 (1989-08-01), Bowen et al.
patent: 4895719 (1990-01-01), Radhakrishnan et al.
patent: 4906417 (1990-03-01), Gentry
patent: 4917119 (1990-04-01), Potter et al.
patent: 4941483 (1990-07-01), Ridings et al.
patent: 5049389 (1991-09-01), Radhakrishnan
patent: 5099861 (1992-03-01), Clearman et al.
patent: 5146915 (1992-09-01), Montgomery
patent: 5366770 (1994-11-01), Wang
patent: 5388574 (1995-02-01), Ingebrethsen
patent: 5456247 (1995-10-01), Shilling et al.
patent: 5456677 (1995-10-01), Spector
patent: 5525329 (1996-06-01), Snyder et al.
patent: 5544646 (1996-08-01), Lloyd et al.
patent: 5592934 (1997-01-01), Thwaites
patent: 5605146 (1997-02-01), Sarela
patent: 5649554 (1997-07-01), Sprinkel et al.
patent: 5694919 (1997-12-01), Rubsamen et al.
patent: 5735263 (1998-04-01), Rubsamen et al.
patent: 5738865 (1998-04-01), Baichwal et al.
patent: 5743251 (1998-04-01), Howell et al.
patent: 5758637 (1998-06-01), Ivri et al.
patent: 5840246 (1998-11-01), Hammons et al.
patent: 5874481 (1999-02-01), Weers et al.
patent: 5894841 (1999-04-01), Voges
patent: 5900416 (1999-05-01), Markson
patent: 5915378 (1999-06-01), Lloyd et al.
patent: 5918595 (1999-07-01), Olsson et al.
patent: 5934272 (1999-08-01), Lloyd et al.
patent: 5957124 (1999-09-01), Lloyd et al.
patent: 5960792 (1999-10-01), Lloyd et al.
patent: 5993805 (1999-11-01), Sutton et al.
patent: 6041777 (2000-03-01), Faithfull et al.
patent: 6051566 (2000-04-01), Bianco
patent: 6089857 (2000-07-01), Matsuura et al.
patent: 6090212 (2000-07-01), Mahawili
patent: 6095134 (2000-08-01), Sievers et al.
patent: 6095153 (2000-08-01), Kessler et al.
patent: 6102036 (2000-08-01), Slutsky et al.
patent: 6125853 (2000-10-01), Susa et al.
patent: 6241969 (2001-06-01), Saidi et al.
patent: 6255334 (2001-07-01), Sands
patent: 6461591 (2002-10-01), Keller et al.
patent: 6506762 (2003-01-01), Horvath et al.
patent: 6514482 (2003-02-01), Bartus et al.
patent: 6591839 (2003-07-01), Meyer et al.
patent: 6632047 (2003-10-01), Vinegar et al.
patent: 6780399 (2004-08-01), Rabinowitz et al.
patent: 2001/0020147 (2001-09-01), Staniforth et al.
patent: 2002/0037828 (2002-03-01), Wilson et al.
patent: 2002/0058009 (2002-05-01), Bartus et al.
patent: 2002/0086852 (2002-07-01), Cantor
patent: 2002/0112723 (2002-08-01), Schuster et al.
patent: 2002/0176841 (2002-11-01), Barker et al.
patent: 2003/0004142 (2003-01-01), Prior et al.
patent: 2003/0032638 (2003-02-01), Kim et al.
patent: 0 358 114 (1990-03-01), None
patent: 0 606 486 (1994-07-01), None
patent: 1 080 720 (2001-03-01), None
patent: 903866 (1962-08-01), None
patent: WO 91/07947 (1991-06-01), None
patent: WO 94/09842 (1994-05-01), None
patent: WO 96/00071 (1996-01-01), None
patent: WO 96/09846 (1996-04-01), None
patent: WO 96/13161 (1996-05-01), None
patent: WO 96/13290 (1996-05-01), None
patent: WO 96/13291 (1996-05-01), None
patent: WO 96/13292 (1996-05-01), None
patent: WO 96/30068 (1996-10-01), None
patent: WO 97/27804 (1997-08-01), None
patent: WO 98/22170 (1998-05-01), None
patent: WO 98/31346 (1998-07-01), None
patent: WO 98/36651 (1998-08-01), None
patent: WO 99/16419 (1999-04-01), None
patent: WO 99/64094 (1999-12-01), None
patent: WO 00/00176 (2000-01-01), None
patent: WO 00/00215 (2000-01-01), None
patent: WO 00/27363 (2000-05-01), None
patent: WO 00/29053 (2000-05-01), None
patent: WO 00/47203 (2000-09-01), None
patent: WO 00/64940 (2000-11-01), None
patent: WO 00/66084 (2000-11-01), None
patent: WO 00/66206 (2000-11-01), None
patent: WO 00/76673 (2000-12-01), None
patent: WO 01/05459 (2001-01-01), None
patent: WO 01/13957 (2001-03-01), None
patent: WO 01/41732 (2001-06-01), None
patent: WO 01/80829 (2001-11-01), None
patent: WO 02/24158 (2002-03-01), None
Office Action mailed Aug. 13, 2003 for U.S. application 10/153,313 filed May 21, 2002 “Delivery of Benzodiazepines through an Inhalation Route”.
Bennett, R.L. et al. (1981). “Patient-Controlled Analgesia: A New Concept of Postoperative Pain Relief,” Annual Surg. 195(6):700-705.
Carroll, M.E. et al. (1990), “Cocaine-base smoking in rhesus monkeys: reinforcing and physiological effects,”Psychopharmacology(Berl). 102:443-450.
Clark, A. and Byron, P. (1986). “Dependence of Pulmonary Absorption Kinetics on Aerosol Particle Size,”Z. Erkrank.166:13-24.
Darquenne, C. et al. (1997). “Aerosol Dispersion in Human Lung: Comparison Between Numerical Simulations and Experiments for Bolus Tests,”American Physiological Society.966-974.
Database WPI, Section CH, Week 198941, Derwent Publications Ltd., London, GB; AN 1989-297792 AP002230849 & JP 01 221313 (Nippon Create KK), Sep. 4, 1989, abstract.
Davies, C.N. et al. (May 1972). “Breathing of Half-Micron Aerosols,”Journal of Applied Physiology.32(5):591-600.
Dershwitz, M., M.D., et al. (Sep. 2000). “Pharmacokinetics and Pharmacodynamics of Inhaled versus Intravenous Morphine in Healthy Volunteers,”Anesthesiology.93(3): 619-628.
Finlay, W.H. (2001). “The Mechanics of Inhaled Pharmaceutical Aerosols”, Academic Press: San Diego Formula 2.39. pp. 3-14 (Table of Contents). pp. v-viii.
Gonda,I. (1991). “Particle Deposition in the Human Respiratory Tract,” Chapter 176,The Lung: Scientific Foundations.Crystal R.G. and West, J.B. (eds.), Raven Publishers, New York. pp. 2289-2294.
Hatsukami D, et al. (May 1990) “A method for delivery of precise doses of smoked cocaine-base to humans.”Pharmacology Biochemistry&Behavior.36(1):1-7.
Heyder, J. et al. (1986). “Deposition of Particles in the Human Respiratory Tract in the Size Range 0.005-15 μm,”J. Aerosol Sci.17(5):811-822.
Huizer, H., “Analytical studies on illicit heron. V. Efficacy of volatilization during heroin smoking.”Pharmaceutisch Weekblad Scientific Edition(1987). 9(4):203-211.
Hurt, R.D., MD and Robertson, C.R., PhD, (Oct. 1998). “Prying Open the Door to the Tobacco Industry's Secrets About Nicotine: The Minnesota Tobacco Trial,”JAMA280(13):1173-1181.
Lichtman, A.H. et al. (1996). “Inhalation Exposure to Volatilized Opioids Produces Antinociception in Mice,”Journal of Pharmacology and Experimental Therapeutics.279(1):69-76.
Martin, B.R. and Lue, L.P. (May/Jun. 1989). “Pyrolysis and Volatilization of Cocaine,”Journal of Analytical Toxicology13:158-162.
Mattox, A.J. and Carroll, M.E., (1996). “Smoked heroin self-administration in rhesus monkeys,”Psychopharmacology, 125:195-201.
Meng, Y. et al. “Inhalation Studies With Drugs of Abuse, ”NIDA Research Monograph, (1997) 173:201-224.
Meng, Y., et al. (1999). “Pharmacological effects
Alexza Pharmaceuticals, Inc.
Haghighatian M.
Hartley Michael G.
Leschensky William L.
Swanson & Bratchun LLC
LandOfFree
Delivery of caffeine through an inhalation route does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Delivery of caffeine through an inhalation route, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Delivery of caffeine through an inhalation route will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3588557